Skip to content

Clinical effect of Qihuang acupuncture on Parkinson's depression

Clinical effect of Qihuang acupuncture on Parkinson's depression

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400084891
Enrollment
Unknown
Registered
2024-05-27
Start date
2024-05-27
Completion date
Unknown
Last updated
2024-06-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's depression

Interventions

Treatment group:Provide Qihuang acupuncture therapy on top of basic treatment.
Control group:Apply false needle acupuncture on top of basic treatment.

Sponsors

The First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 75 Years

Inclusion criteria

Inclusion criteria: (a) Meet the diagnostic criteria for Parkinson's depression; (b) Aged 30-75 years; (c) The course of the disease is less than 10 years; (d) Hoehn-Yahr rating within 1-3; (e) Depression was classified as mild depression (f) Those receiving anti-PDD medication and taking steady doses, or those not receiving medication; (g) Clear consciousness, stable vital signs, no obvious intellectual disability, no obvious hearing impairment, no history of suicide, self-harm or inclination; (h) The person who signed the informed consent.

Exclusion criteria

Exclusion criteria: (a) Parkinson's syndrome and Parkinson's syndrome caused by various causes such as cerebrovascular disease and poisoning; (b) Those with more serious diseases, such as serious liver, kidney, blood, neoplasms, endocrine diseases or pain; (c) Participants in clinical trials of other drugs and acupuncture simultaneously; (d) Depression is classified as major depression, mental illness, or a history or tendency to commit suicide or self-harm; (e) Persons who are deaf or have communication difficulties; (f) Persons with a history of alcohol or drug abuse.

Design outcomes

Primary

MeasureTime frame
Hamilton Depression Scale-24, HAMD-24;

Secondary

MeasureTime frame
functional connectivity,FC;Nrf2 ;NLRP3;Caspase-1;Hoehn-Yahr;UPDRS?;

Countries

China

Contacts

Public ContactChen Zhenhu

The First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine

wydwl1991@163.com+86 137 2806 3180

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026